Skip to main content
. 2023 Nov 4;13(1):161–178. doi: 10.1007/s40123-023-00829-3

Fig. 4.

Fig. 4

Change in mean VA from baseline to months 12 and 24 following intravitreal aflibercept treatment in treatment-naïve and previously treated patients stratified by their baseline. VA, visual acuity